BSE filing, NSE: ELFORGE. Summary written from the filing by ALFA Finder's alert engine.
EL Forge Ltd: key numbers
- Share price
- ₹21.60
- Market cap
- ₹43.90 Cr
- Revenue (annual)
- ₹80.41 Cr
- Net profit (annual)
- ₹2.44 Cr
- P/E (TTM)
- 13.7×Sector 31.4×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EL Forge Ltd
All →EL Forge Management Change
El Forge's Independent Director S. Balakrishnan ceased to hold office after completing his five-year term on 12 October 2026. The departure has no financial or operational impact on the company.
EL Forge Management Change
El Forge Limited appointed Mrs. Shubha Ganesh as a Non-Executive Independent Director for a five-year term, effective September 29, 2026.
EL Forge Annual General Meeting
El Forge Ltd announced results of its postal ballot, confirming the appointment and re-appointment of its Independent Directors. All resolutions were passed by majority vote.
EL Forge Annual General Meeting
EL Forge Limited issued a Postal Ballot notice for the re-appointment of Mrs. Shubha Ganesh and appointment of Mr. M.S. Sivakaminathan as Independent Directors.
EL Forge Management Change
EL Forge Limited announced the cessation of Shubha Ganesh as Independent Director effective July 29, 2026. M/s. VRKSJP & CO. was appointed as Internal Auditor for a three-year term.
- Execution
- 36 months
EL Forge Q1 FY27 Results: Net Profit ₹1.2 Cr, Up 200.0% YoY
EL Forge Ltd reported revenue from operations of ₹21.8 Cr (+5.8% YoY) and net profit of ₹1.2 Cr (+200.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.2 Cr · +200.0% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.